Company intelligence / Profile preview

Institut Mérieux

Lyon, France

Ownership: Private
Development stage: Other

Overview

Institut Mérieux is a global life sciences holding company specializing in diagnostics, immunotherapy, public health, and nutrition, with major subsidiaries including bioMérieux (diagnostics), Transgene (cancer/infectious disease immunotherapy), and Mérieux NutriSciences (food safety and nutrition). Subsidiary pipeline stages range from preclinical to commercial, particularly in cancer immunotherapies and infectious disease solutions.

Therapeutic areas: OncologyInfectious Diseases
Modalities: VaccineImmunotherapyDiagnosticsGene therapyMonoclonal antibodySmall moleculeBiologic
Industry: Biotech

Drug pipeline

2 assets

group a meningococcal polysaccharide vaccine

1 more asset in the full pipeline.

Request access →

Partnerships

Sanofi Pasteur (historical, via vaccine legacy)Various biotech/health/academia institutions worldwide

Beyond the preview

Go deeper on Institut Mérieux.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Institut Mérieux.

Explore the full profile